(Q38201284)

30 August 2017

title

Network meta-analysis for comparing treatment effects of multiple interventions: an introduction (English)

1 reference

30 August 2017

1 reference

1

1 reference

30 August 2017

4

1 reference

30 August 2017

Brian Hutton

5

0 references

Aurelio Tobías

object named as

Aurelio Tobías

series ordinal

2

0 references

author name string

Chris Cameron

series ordinal

3

1 reference

30 August 2017

publication date

2 April 2014

1 reference

Rheumatology International

30 August 2017

published in

1 reference

30 August 2017

volume

34

1 reference

30 August 2017

issue

11

1 reference

30 August 2017

page(s)

1489-1496

1 reference

Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement

30 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS00296-014-2994-2

Simultaneous comparison of multiple treatments: combining direct and indirect evidence.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00296-014-2994-2

Integration of evidence from multiple meta-analyses: a primer on umbrella reviews, treatment networks and multiple treatments meta-analyses

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00296-014-2994-2

How to use an article reporting a multiple treatment comparison meta-analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00296-014-2994-2

Demystifying trial networks and network meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00296-014-2994-2

Borrowing strength from external trials in a meta-analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00296-014-2994-2

The results of direct and indirect treatment comparisons in meta-analysis of randomized controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00296-014-2994-2

Combination of direct and indirect evidence in mixed treatment comparisons

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00296-014-2994-2

Exploring the geometry of treatment networks.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00296-014-2994-2

La propiedad transitiva en los ensayos clínicos controlados: si B es mejor que A y C es mejor que B, ¿C será mejor que A?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00296-014-2994-2

Inconsistency between direct and indirect comparisons of competing interventions: meta-epidemiological study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00296-014-2994-2

Is network meta-analysis as valid as standard pairwise meta-analysis? It all depends on the distribution of effect modifiers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00296-014-2994-2

Impact of reporting bias in network meta-analysis of antidepressant placebo-controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00296-014-2994-2

Adjustment for reporting bias in network meta-analysis of antidepressant trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00296-014-2994-2

The effects of excluding treatments from network meta-analyses: survey

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00296-014-2994-2

A case study of multiple-treatments meta-analysis demonstrates that covariates should be considered

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00296-014-2994-2

Graphical methods and numerical summaries for presenting results from multiple-treatment meta-analysis: an overview and tutorial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00296-014-2994-2

Analysis of the systematic reviews process in reports of network meta-analyses: methodological systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00296-014-2994-2

Review of mixed treatment comparisons in published systematic reviews shows marked increase since 2009.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00296-014-2994-2

A network meta-analysis of randomized controlled trials of biologics for rheumatoid arthritis: a Cochrane overview

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00296-014-2994-2

Indirect comparison of tocilizumab and other biologic agents in patients with rheumatoid arthritis and inadequate response to disease-modifying antirheumatic drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00296-014-2994-2

Comparison of certolizumab pegol with other anticytokine agents for treatment of rheumatoid arthritis: a multiple-treatment Bayesian metaanalysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00296-014-2994-2

A mixed treatment comparison of the short-term efficacy of biologic disease modifying anti-rheumatic drugs in established rheumatoid arthritis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00296-014-2994-2

A mixed treatment comparison of the efficacy of anti-TNF agents in rheumatoid arthritis for methotrexate non-responders demonstrates differences between treatments: a Bayesian approach

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00296-014-2994-2

Evidence synthesis for decision making 4: inconsistency in networks of evidence based on randomized controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00296-014-2994-2

Evidence synthesis for decision making 3: heterogeneity--subgroups, meta-regression, bias, and bias-adjustment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00296-014-2994-2

Evidence synthesis for decision making 2: a generalized linear modeling framework for pairwise and network meta-analysis of randomized controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00296-014-2994-2

Evidence synthesis for decision making 1: introduction

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00296-014-2994-2

Network meta-analysis-highly attractive but more methodological research is needed

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00296-014-2994-2

Biologic agents in rheumatology: unmet issues after 200 trials and $200 billion sales

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00296-014-2994-2

Why the findings of published multiple treatment comparison meta-analyses of biologic treatments for rheumatoid arthritis are different: an overview of recurrent methodological shortcomings

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00296-014-2994-2

Evidence synthesis for decision making 7: a reviewer's checklist

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00296-014-2994-2

Characteristics of networks of interventions: a description of a database of 186 published networks

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00296-014-2994-2

Bayesian methods in meta-analysis and evidence synthesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00296-014-2994-2

Indirect and mixed-treatment comparison, network, or multiple-treatments meta-analysis: many names, many benefits, many concerns for the next generation evidence synthesis tool

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00296-014-2994-2

Conceptual and Technical Challenges in Network Meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00296-014-2994-2

Network meta-analysis for indirect treatment comparisons

21 January 2018

1 reference

12 December 2020

Adverse effects of biologics: a network meta-analysis and Cochrane overview

1 reference

12 December 2020

The Transitive Property Across Randomized Controlled Trials: If B Is Better Than A, and C Is Better Than B, Will C Be Better Than A?

1 reference

12 December 2020

Systematic review and network meta-analysis of combination and monotherapy treatments in disease-modifying antirheumatic drug-experienced patients with rheumatoid arthritis: analysis of American College of Rheumatology criteria scores 20, 50, and 70

1 reference

12 December 2020

Indirect and mixed treatment comparisons in arthritis research

1 reference

12 December 2020

10.1007/S00296-014-2994-2

Identifiers

DOI

1 reference

Dimensions Publication ID

30 August 2017

1002816366

0 references

1 reference